Caretrust REIT Inc (NASDAQ:CTRE) Given Consensus Rating of “Buy” by Brokerages

Share on StockTwits

Caretrust REIT Inc (NASDAQ:CTRE) has earned a consensus rating of “Buy” from the ten research firms that are currently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $23.00.

A number of research firms have recently commented on CTRE. Zacks Investment Research raised shares of HANNOVER RUECK/S from a “sell” rating to a “hold” rating in a research note on Friday, May 17th. Stifel Nicolaus raised shares of Protagonist Therapeutics from a “hold” rating to a “buy” rating and boosted their target price for the stock from $11.00 to $17.00 in a research note on Wednesday, May 8th. Raymond James reissued a “buy” rating on shares of Kelt Exploration in a research note on Friday, May 31st. BidaskClub cut shares of Zynga from a “buy” rating to a “hold” rating in a research note on Tuesday, June 18th. Finally, BMO Capital Markets reissued an “outperform” rating and set a C$28.00 target price on shares of Northland Power in a research note on Tuesday, April 9th.

CTRE traded down $0.06 on Tuesday, reaching $24.07. The stock had a trading volume of 747,485 shares, compared to its average volume of 1,005,863. Caretrust REIT has a 12-month low of $16.29 and a 12-month high of $25.54. The company has a current ratio of 15.94, a quick ratio of 15.94 and a debt-to-equity ratio of 0.84. The company has a 50-day moving average price of $24.36. The company has a market cap of $2.30 billion, a P/E ratio of 18.80 and a beta of 0.78.

Caretrust REIT (NASDAQ:CTRE) last released its quarterly earnings data on Tuesday, May 7th. The real estate investment trust reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.14). The firm had revenue of $39.66 million during the quarter, compared to analysts’ expectations of $40.79 million. Caretrust REIT had a net margin of 37.46% and a return on equity of 8.08%. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 EPS. Analysts predict that Caretrust REIT will post 1.39 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Friday, June 28th will be given a dividend of $0.225 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.90 dividend on an annualized basis and a yield of 3.74%. Caretrust REIT’s payout ratio is presently 70.31%.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. 6 Meridian boosted its position in Caretrust REIT by 1.5% during the second quarter. 6 Meridian now owns 33,263 shares of the real estate investment trust’s stock worth $791,000 after acquiring an additional 507 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in Caretrust REIT by 1.8% during the first quarter. Oregon Public Employees Retirement Fund now owns 32,487 shares of the real estate investment trust’s stock worth $762,000 after acquiring an additional 587 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Caretrust REIT by 4.7% during the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 16,573 shares of the real estate investment trust’s stock worth $389,000 after acquiring an additional 750 shares during the last quarter. Amalgamated Bank boosted its position in Caretrust REIT by 7.0% during the fourth quarter. Amalgamated Bank now owns 12,037 shares of the real estate investment trust’s stock worth $222,000 after acquiring an additional 791 shares during the last quarter. Finally, Raymond James & Associates boosted its position in Caretrust REIT by 2.1% during the fourth quarter. Raymond James & Associates now owns 49,321 shares of the real estate investment trust’s stock worth $910,000 after acquiring an additional 1,036 shares during the last quarter. Hedge funds and other institutional investors own 84.72% of the company’s stock.

Caretrust REIT Company Profile

CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.

Recommended Story: Municipal Bonds

Analyst Recommendations for Caretrust REIT (NASDAQ:CTRE)

Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.